• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

E-098 Initial experience with the pipeline vantage flow diverter - vantage one study: six-month results, technical and clinical consideration
ConclusionThe new PVED reveals improved device visibility, ease of delivery and repositioning with precise distal opening in comparison to previous PED generations. Initial results demonstrate overall good device performance, safety profile and effectiveness. The implant requires a modified deployment technique for successful vessel wall apposition of the proximal stent as opposed to the previous generations of PED.ReferencesLylyk I, Scrivano E, Lundquist J, Ferrario A, Bleise C, Perez N, Lylyk PN, Viso R, Nella-Castro R, Lylyk P. Pipeline embolization devices for the treatment of intracranial aneurysms, single-center regi...
Source: Journal of NeuroInterventional Surgery - July 30, 2023 Category: Neurosurgery Authors: de Viliers, L., Carraro do Nascimento, V., Domitrovic, L., Rice, H. Tags: SNIS 20th annual meeting electronic poster abstracts Source Type: research

Development of a machine learning-based real-time location system to streamline acute endovascular intervention in acute stroke: a proof-of-concept study
Conclusions ML-based RTLS technology using WiFi fingerprinting has the potential to streamline delivery of acute stroke endovascular intervention by efficiently tracking patient and staff movement during stroke calls.
Source: Journal of NeuroInterventional Surgery - July 14, 2022 Category: Neurosurgery Authors: Lim, D. Z., Yeo, M., Dahan, A., Tahayori, B., Kok, H. K., Abbasi-Rad, M., Maingard, J., Kutaiba, N., Russell, J., Thijs, V., Jhamb, A., Chandra, R. V., Brooks, M., Barras, C., Asadi, H. Tags: Vascular neurology Source Type: research

E-034 EndoVascular treatment of wide-neck aneurysms, an evaluation of safety and effectiveness of stryker surpass evolve™ flow diverter system
ConclusionThe EVOLVE prospective, multicenter, single arm, pre-market study (ClinicalTrials.gov NCT: NCT04195568), is designed to evaluate the safety, efficacy, and performance of the Surpass EVOLVE Flow Diverter System in the treatment of unruptured wide-neck, saccular or fusiform IA located in the ICA and its branches with an RVD of 2.5 to 5.0 mm.Disclosures A. Arthur: 2; C; Stryker Neurovascular. J. Fifi: 1; C; Stryker Neurovascular. 2; C; Stryker Neurovascular. H. Rice: 2; C; Stryker Neurovascular. A. Wakhloo: 2; C; Stryker Neurovascular. A. Coon: 2; C; Stryker Neurovascular. V. Pereira: 2; C; Stryker, Medtronic, Balt, Cerenovus.
Source: Journal of NeuroInterventional Surgery - July 26, 2021 Category: Neurosurgery Authors: Arthur, A., Fifi, J., Rice, H., Wakhloo, A., Coon, A., Pereira, V. Tags: Electronic poster abstracts Source Type: research